1. Home
  2. SLE vs ENSC Comparison

SLE vs ENSC Comparison

Compare SLE & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$0.51

Market Cap

3.1M

ML Signal

HOLD

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.92

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLE
ENSC
Founded
2014
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
3.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SLE
ENSC
Price
$0.51
$0.92
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
262.2K
119.4K
Earning Date
11-13-2025
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,568,000.00
$4,487,973.00
Revenue This Year
N/A
N/A
Revenue Next Year
$20.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.51
52 Week Low
$0.53
$0.76
52 Week High
$26.00
$8.97

Technical Indicators

Market Signals
Indicator
SLE
ENSC
Relative Strength Index (RSI) 34.90 37.65
Support Level $0.62 $0.76
Resistance Level $0.76 $0.95
Average True Range (ATR) 0.08 0.09
MACD 0.02 0.02
Stochastic Oscillator 9.11 47.80

Price Performance

Historical Comparison
SLE
ENSC

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: